Shanghai, China - MicroPort EverPace's latest generation Columbus™ 3D EP Navigation System (Columbus™) has recently received CE MDR approval.

The 3D EP Navigation System represents a groundbreaking advancement in tachyarrhythmia treatment. This system merges hardware circuits, software systems and core algorithms, having a lengthy R&D cycle and high technical barriers. To fulfill clinical needs for high precision, stability and reliability, it places high demands in its components and overall structure.

The latest generation Columbus™ System includes two models. The EPE-SYS-2A, building upon its predecessor, adds an electrical positioning module and offers a new software interface  more closely aligned with clinical needs. The Model EPE-SYS-1A features a completely new system architecture, boasting enhanced signal processing capabilities, more electrode positioning and signal channels, and integrates a direct catheter interface, electromagnetic positioning, ECG signal acquisition, and other modules, meeting higher precision clinical needs and providing more valuable information for clinical applications.

Up to now, the Columbus™ system has successfully completed over 50,000 tachyarrhythmia treatment. In the future, MicroPort EverPace will remain committed to providing more high-quality and innovative products to the global market, providing a comprehensive electrophysiology treatment and diagnostic integrated solution for patients worldwide.